The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for structural heart disease

The Leaflex™ Catheter System – a viable treatment option alongside valve replacement? Preclinical feasibility of a novel device designed for fracturing aortic valve calcification

EuroIntervention 2015;11:582-590 published online ahead of print November 2014. DOI: 10.4244/EIJY14M11_10

1. Kaplan Medical Center, Rehovot, Israel; 2. Wolfson Medical Center, Holon, Israel; 3. Assuta Hospital, Tel Aviv, Israel; 4. Sheba Medical Center, Tel Hashomer, Israel; 5. Pi-Cardia, Rehovot, Israel

Aims: To demonstrate the feasibility of the Leaflex™ Catheter System, a novel percutaneous device for fracturing valve calcification using mechanical impact in or

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Proof of concept of FOLDAVALVE, a novel 14 Fr totally repositionable and retrievable transcatheter aortic valve